Inventor · disambiguated record
Didier Branellec
Also filed as: BRANELLEC DIDIER
6 granted patents·8 pending applications·121 citations·filing 1995–2006
83Inventor score
Files withAVENTIS PHARMA SA3UNIV CALIFORNIA2UNIV CASE WESTERN RESERVE2CENTELION SAS1LUDWIG INST CANCER RES1
Top patents by PatentIndex Score
14 records- 0190US5851521AViral vectors and their use for treating hyperproliferative disorders, in particular restenosisUNIV CASE WESTERN RESERVE·Filed 1996·Granted Dec 22, 1998·87 cites·36 claims
- 0275US6793918B2In vivo stimulation of angiogenic activityLUDWIG INST CANCER RES·Filed 2001·Granted Sep 21, 2004·12 cites·24 claims
- 0374US7193075B2Sequences upstream of the CARP gene, vectors containing them and uses thereofUNIV CALIFORNIA·Filed 2001·Granted Mar 20, 2007·2 cites·17 claims
- 0459US6410011B1Gene therapy for restenosis using an adenoviral vectorAVENTIS PHARMA SA·Filed 1995·Granted Jun 25, 2002·15 cites·24 claims
- 0555US2006110362A1Sequences upstream of the CARP gene, vectors containing them and uses thereofUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 0654USRE37933EViral vectors and their use for treating hyperproliferative disorders, in particular restenosisUNIV CASE WESTERN RESERVE·Filed 2000·Granted Dec 10, 2002·0 cites·50 claims
- 0754US2007150971A1Sequences upstream of the carp gene, vectors containing them and uses thereofUNIV CALIFORNIA AND CENTELION·Filed 2006·Application pending·0 cites
- 0851US2005004058A1Sequences upstream of the carp gene, vectors containing them and uses thereofFiled 2004·Application pending·0 cites
- 0948US2002094324A1Gene therapy for restenosis using an adenoviral vectorAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 1045US2003100889A1Method of administration of a gene of interest to a vascular tissueFiled 2002·Application pending·0 cites
- 1139US6121005APolypeptides comprising domains of the GAX protein implicated in the repression of transcription and/or interaction with other proteins, corresponding nucleic acids, and their useAVENTIS PHARMA SA·Filed 1997·Granted Sep 19, 2000·5 cites·11 claims
- 1235US2005096286A1Treatment of hypercholesterolemia or diabetes associated angiogenic defectsCENTELION SAS·Filed 2004·Application pending·0 cites
- 1333US2002086004A1Use of a defective recombinant adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertensionFiled 2001·Application pending·0 cites
- 1423US2002144302A1Novel constructs and vectors for the targeted and inducible expression of genesFiled 1997·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →